# Breathlessness Exertion and Morphine Sulphate

> **NCT02720822** · PHASE3 · COMPLETED · sponsor: **Flinders University** · enrollment: 171 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- Dyspnea

## Interventions

- **DRUG:** Placebo
- **DRUG:** Morphine Sulfate
- **DRUG:** Plus laxative (Docusate with senna)
- **DRUG:** Plus placebo laxative
- **DEVICE:** FitBit charge HR (Accelerometer)

## Key facts

- **NCT ID:** NCT02720822
- **Lead sponsor:** Flinders University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-08
- **Primary completion:** 2019-12-20
- **Final completion:** 2019-12-20
- **Target enrollment:** 171 (ESTIMATED)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02720822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02720822, "Breathlessness Exertion and Morphine Sulphate". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02720822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*